Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 12-2014 | 09-2014 | 12-2013 | |
| Sales | 14,694 | 43,744 | 43,744 | 0 | 12,400 |
| Cost of Goods | 3,873 | 4,013 | 4,013 | N/A | 590 |
| Gross Profit | 10,821 | 39,731 | 11,520 | N/A | 11,810 |
| Operating Expenses | 135,065 | 127,461 | 33,332 | 0 | 18,250 |
| Operating Income | -123,372 | -87,718 | 6,412 | N/A | -5,850 |
| Interest Expense | 246 | 115 | 115 | 0 | 30 |
| Other Income | 866 | 374 | -93,756 | 0 | 40 |
| Pre-tax Income | -122,752 | -87,459 | -87,459 | 0 | -5,840 |
| Income Tax | -32,073 | -19,156 | -19,156 | N/A | -1,170 |
| Net Income Continuous | -90,679 | -68,303 | -23,776 | N/A | -7,359 |
| Net Income | $-90,679 | $-68,303 | $-68,303 | $N/A | $-4,660 |
| EPS Basic Total Ops | -4.02 | -3.33 | -1.36 | N/A | -0.59 |
| EPS Basic Continuous Ops | -4.02 | -3.33 | -1.36 | N/A | -0.59 |
| EPS Diluted Total Ops | -4.02 | -3.33 | -1.36 | N/A | -0.59 |
| EPS Diluted Continuous Ops | -4.02 | -3.33 | -1.36 | N/A | -0.59 |
| EBITDA(a) | $-118,148 | $-84,189 | $7,172 | $N/A | $-5,350 |